Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 4/20 | 0.60 |
| ▸ | CA2 | P00918 | 4/20 | 0.60 |
| ▸ | CA12 | O43570 | 3/20 | 0.60 |
| ▸ | CA7 | P43166 | 3/20 | 0.60 |
| ▸ | CA9 | Q16790 | 3/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | XDH | P47989 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | GFER | P55789 | 1/20 | 0.58 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.58 |
| ▸ | RELA | Q04206 | 1/20 | 0.58 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70232 | 0.95 | ATM (0.61) | CNR2ATMCA1CA2CA12 | |
| SCHEMBL3349389 | 0.89 | CNR2 (0.56) | CNR2ATMCA1CA2CA12 | |
| SCHEMBL31401266 | 0.89 | CNR2 (0.56) | CNR2ATMCA1CA2CA12 | |
| Methyl 3,5-Dimethylbenzoate SCHEMBL9579696 | 0.88 | TSHR (0.73) | CNR2ATMTDP1KDM4ELMNA | |
| SCHEMBL3351858 | 0.87 | ATM (0.53) | CNR2ATMCA1CA2CA12 | |
| SCHEMBL31208002 | 0.87 | CA12 (0.76) | CNR2ATMCA1CA2CA12 | |
| SCHEMBL2259905 | 0.87 | CA12 (0.76) | CNR2ATMCA1CA2CA12 | |
| SCHEMBL166126 | 0.87 | TPMT (0.64) | CNR2ATMCA1CA2CA12 | |
| SCHEMBL18938219 | 0.85 | ATM (0.52) | CNR2ATMCA1CA2CA12 | |
| SCHEMBL839253 | 0.85 | NOTUM (0.59) | CNR2ATMCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118879796-A | Method for synthesizing methyl salicylate compound by taking biological enzyme as catalyst | 济南大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118240886-A | Method for synthesizing ethyl salicylate compound by biological enzyme catalysis | 济南大学 | 2024-06-25 | — | — | CN | claimed |
| US-20230234918-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-07-27 | — | — | US | claimed |
| CN-112851506-B | Industrial preparation method of 3, 5-dimethoxy-4-alkyl benzyl alcohol | 湖北英纳氏生物科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4178942-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | Council Of Scientific & Industrial Research (IN) | 2023-05-17 | — | — | EP | claimed |
| CN-115956066-A | Automatic diazomethane generator, reactor and solid phase quenching agent | 科学与工业研究委员会 | 2023-04-11 | — | — | CN | claimed |
| WO-2022044038-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-03 | — | — | WO | claimed |
| CN-112851506-A | Industrial preparation method of 3, 5-dimethoxy, 4-alkyl benzyl alcohol | 湖北英纳氏生物科技有限公司 | 2021-05-28 | — | — | CN | claimed |
| CN-104387332-B | A kind of method of synthetic aroma enzyme inhibitors | JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD. (CN) | 2016-04-13 | — | — | CN | claimed |
| CN-103342663-B | A kind of preparation method of Anastrozole key intermediate | ASYMCHEM MEDICAL GROUP (TIANJIN) INC. (CN) | 2015-07-29 | — | — | CN | claimed |
| CN-104387332-A | Method for synthesizing aromatase inhibitor | JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO LTD | 2015-03-04 | — | — | CN | claimed |
| CN-103342663-A | Method for preparing key anastrozole intermediate | ASYMCHEM LAB TIANJIN CO LTD | 2013-10-09 | — | — | CN | claimed |
| JP-2008500943-A | — | — | 2008-01-17 | — | — | JP | claimed |
| EP-1622717-A2 | AFFINITY-BASED ENRICHMENT OF PHOSPHORYLATED PEPTIDES AND/OR PROTEINS | ProteoSys AG (DE) | 2006-02-08 | — | — | EP | claimed |
| WO-2004099233-A2 | AFFINITY-BASED ENRICHMENT OF PHOSPHORYLATED PEPTIDES AND/OR PROTEINS | PROTEOSYS AG (DE) | 2004-11-18 | — | — | WO | claimed |
| CN-122055358-A | GPR65 small molecule regulator and preparation method and application thereof | 四川大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-4042603-A | SUBSTITUTED DIBENZOFURAN OR 9-FLUORENONE FROM A DIPHENYL ETHER OR BENZOPHENONE | UBE INDUSTRIES, LTD. (JA) | 1977-08-16 | — | — | US | disclosed |
| US-4042704-A | FERTILITY CONTROL AGENTS | SANDOZ, INC. (US) | 1977-08-16 | — | — | US | disclosed |
| US-3992435-A | USED FOR THE FORMATION OF POLYESTERS | STANDARD OIL COMPANY (INDIANA) (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | MRGPRX4, MRGPRX1, MRGPRX2 | CNR2 56/4885ATM 2893/4885CA1 1377/4885 |
| US-20230234918-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | FTO, MNAT1, ALKBH2 | CNR2 1024/4885ATM 432/4885CA1 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.